Pros | ![]() 5Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | 1/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 9 Years | 7 Years | ||
Fund Size | 1296 Cr | 6227 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.62% | 1.04% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 43 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (10.03%) Apollo Hospitals Enterprise Ltd (5.06%) Lupin Ltd (4.88%) Cipla Ltd (4.86%) Torrent Pharmaceuticals Ltd (4.68%) | Sun Pharmaceuticals Industries Ltd (11.58%) Dr Reddy's Laboratories Ltd (9.1%) Divi's Laboratories Ltd (8.75%) Aurobindo Pharma Ltd (8.25%) Cipla Ltd (6.92%) | ||
No of Sectors | 3 | 3 | ||
Top 3 Sectors | Health (95.71%) Basic Materials (2.68%) Financial Services (1.61%) | Health (97.7%) Basic Materials (1.18%) Financial Services (1.12%) | ||
Equity % | 98.28% | 97.55% | ||
Debt % | - | - | ||
P/E | 39.89 | 30.65 | ||
P/B | 6.32 | 4.17 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.27% | -0.73% | ||
3-Month Return | 0.09% | -0.53% | ||
6-Month Return | 8.26% | 11.84% | ||
1-Year Return | -0.09% | 3.49% | ||
3-Year Return | 24.59% | 29.2% | ||
5-Year Return | 19.44% | 21.36% |
Sharpe | 1 | 1.24 | ||
Alpha | 4.32 | 4.3 | ||
Beta | 0.94 | 0.95 | ||
Standard Deviation | 16.07 | 15.67 | ||
Information Ratio | 1.35 | 1.4 |
Description | Tata India Pharma & Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Dharmesh Kakkad,Sharmila D’mello |